Uniportal Robotic Lobectomy and Lymphadenectomy for Invasive Lung Cancer: A Novel Approach and Perioperative Outcomes
Thoracic Cancer · 2025-01 · 16 (1)
DOI: 10.1111/1759-7714.15500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thoracic Cancer, online erschienen am 27.11.2024. Verfasst von Shengcheng Lin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Ac…. Hauptthemen laut MEDLINE: Lymph Node Excision, Lung Neoplasms, Robotic Surgical Procedures, Pneumonectomy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital Chinese Academy of Medical Sciences and Peking Union Me…, The Sanming Project of Medicine in Shenzhen, The Cancer Hospital, Chinese Academy of Medical Sciences, Shenzhen Center/Shenzhen Cancer Hospital Research Project.
Abstract (Originalsprache)
Background
Multiport robot‐assisted thoracoscopic surgery (mRATS) has been comprehensively evaluated for its clinical efficacy in numerous studies. Nevertheless, the safety and feasibility of uniportal robotic lobectomy and lymphadenectomy require further validation.
Methods
The clinical data of 34 consecutive patients with lung cancer who underwent improved uniportal robotic‐assisted thoracoscopic surgery (uRATS) at our hospital between November 2023 and June 2024 were reviewed retrospectively. Camera‐centered uRATS was conducted using the da Vinci Surgical Xi system (Intuitive Surgical Inc., 1266 Kifer Road, Sunnyvale, CA 94086, USA). Descriptive statistics are expressed as numbers with percentages for categorical data or medians (ranges) or means with standard deviations for continuous data.
Results
Improved uRATS lobectomy and lymphadenectomy were conducted in 34 patients with postoperative pathology‐diagnosed invasive lung cancer. Among the patients, the median number of lymph nodes dissected was 24.5 (range 10–42), and the median number of stations with lymph nodes dissected was 8 (range 6–11). The median durations of the operation and the uRATS procedure were 200 min (range, 142–330 min) and 140 min (range, 80–242 min), and the median intraoperative blood loss volume was 20 mL (range, 10–100 mL), respectively. All postoperative complications, including pneumonia (2/34, 5.8%), air leakage > 5 days (2/34, 5.8%), prolonged wound healing (1/34, 2.9%), and arrhythmia (1/34, 2.9%), were graded as Clavien–Dindo grades I–II. There were no cases of wound infection or postoperative 30‐day mortality.
Conclusion
The safety and feasibility of uRATS lobectomy and lymphadenectomy using the da Vinci Surgical Xi system have been preliminarily validated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen,…
- Department of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Gu…
ORCID-Profile: Shengcheng Lin, Xiangyang Yu
Förderung
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital Chinese Academy of Medical Sciences and Peking Union Me…
- The Sanming Project of Medicine in Shenzhen
- The Cancer Hospital, Chinese Academy of Medical Sciences, Shenzhen Center/Shenzhen Cancer Hospital Research Project
- Shenzhen Clinical Research Center for Cancer, Cooperation Fund of CHCAMS and SZCH
- Sanming Project of Medicine in Shenzen Municipality
Zitieren
APA
Lin, S., Yu, X., Xu, Y., Xin, Y., He, J., Yu, Z., Zhao, H., Yang, C., & Ma, K. (2025). Uniportal Robotic Lobectomy and Lymphadenectomy for Invasive Lung Cancer: A Novel Approach and Perioperative Outcomes. Thoracic Cancer, 16(1). https://doi.org/10.1111/1759-7714.15500
Vancouver
Lin S, Yu X, Xu Y, Xin Y, He J, Yu Z, et al. Uniportal Robotic Lobectomy and Lymphadenectomy for Invasive Lung Cancer: A Novel Approach and Perioperative Outcomes. Thoracic Cancer. 2025;16(1). doi:10.1111/1759-7714.15500
BibTeX
@article{Lin2025,
author = {Lin, Shengcheng and Yu, Xiangyang and Xu, Yafei and Xin, Yu and He, Jie and Yu, Zhentao and Zhao, Hongbo and Yang, Chenglin and Ma, Kai},
title = {Uniportal Robotic Lobectomy and Lymphadenectomy for Invasive Lung Cancer: A Novel Approach and Perioperative Outcomes},
journal = {Thoracic Cancer},
year = {2025},
volume = {16},
number = {1},
doi = {10.1111/1759-7714.15500}
}
EUVIMED